Here, we aim to improve our understanding of various colorectal cancer (CRC) risk factors (obesity, unhealthy diet, and gut microbiota/metabolome alteration), analyzing 120 patients with colon polyps, divided in normal-weight (NW) or overweight/obese (OB). Dietary habits data (validated EPIC questionnaires) revealed a higher consumption of processed meat among OB vs. NW patients. Both mucosa-associated microbiota (MAM) on polyps and lumen-associated microbiota (LAM) analyses uncovered distinct bacterial signatures in the two groups. Importantly, we found an enrichment of the pathogenic species Finegoldia magna in MAM of OB patients, regardless of their polyp stage. We observed distinct mucosal-associated metabolome signatures, with OB patients showing increased pyroglutamic acid and reduced niacin levels, and performed microbiota-metabolome integrated analysis. These findings support a model where different risk factors may contribute to tumorigenesis in OB vs. NW patients, highlighting the potential impact of processed meat consumption and F. magna on CRC development among OB patients.
Gut microbiota and metabolome signatures in obese and normal-weight patients with colorectal tumors
La Vecchia, MartaPrimo
;Clavenna, Michela Giulia;Sculco, Marika;Sala, Gloria;Marradi, Denise;Barberis, Elettra;Joseph, Soni;Mellai, Marta;Boldorini, Renzo;Azzimonti, Barbara;Bona, Elisa;Prodam, Flavia;Sacerdote, Carlotta;Ferrante, Daniela;Manfredi, Marcello;Aspesi, AnnaCo-ultimo
;Dianzani, Irma
Co-ultimo
2025-01-01
Abstract
Here, we aim to improve our understanding of various colorectal cancer (CRC) risk factors (obesity, unhealthy diet, and gut microbiota/metabolome alteration), analyzing 120 patients with colon polyps, divided in normal-weight (NW) or overweight/obese (OB). Dietary habits data (validated EPIC questionnaires) revealed a higher consumption of processed meat among OB vs. NW patients. Both mucosa-associated microbiota (MAM) on polyps and lumen-associated microbiota (LAM) analyses uncovered distinct bacterial signatures in the two groups. Importantly, we found an enrichment of the pathogenic species Finegoldia magna in MAM of OB patients, regardless of their polyp stage. We observed distinct mucosal-associated metabolome signatures, with OB patients showing increased pyroglutamic acid and reduced niacin levels, and performed microbiota-metabolome integrated analysis. These findings support a model where different risk factors may contribute to tumorigenesis in OB vs. NW patients, highlighting the potential impact of processed meat consumption and F. magna on CRC development among OB patients.File | Dimensione | Formato | |
---|---|---|---|
main.pdf
file ad accesso aperto
Descrizione: La Vecchia et al. 2025
Tipologia:
Versione Editoriale (PDF)
Licenza:
Creative commons
Dimensione
4.07 MB
Formato
Adobe PDF
|
4.07 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.